Related Experiment Video
Updated: Mar 30, 2026

08:49
External Cephalic Version: Is it an Effective and Safe Procedure?
Published on: June 6, 2020
16.0K
Subsequent pregnancy outcome after preterm breech delivery, a population based cohort study
Lester Bergenhenegouwen1, Sabine Ensing2,3, Anita C J Ravelli3
1a Department of Obstetrics and Gynaecology , ZGT , Almelo , The Netherlands .
Summary
For women with a preterm breech delivery, a planned cesarean section does not improve outcomes in a subsequent pregnancy. Perinatal mortality and adverse neonatal outcomes were similar between planned cesarean and planned vaginal delivery groups.
Area of Science:
- Obstetrics and Gynecology
- Perinatal Medicine
- Reproductive Health
Background:
- Preterm breech presentation in pregnancy poses delivery challenges.
- Mode of delivery decisions for preterm breech births impact maternal and neonatal outcomes.
- The effect on subsequent pregnancies requires further investigation.
Purpose of the Study:
- To evaluate the impact of delivery mode in women with preterm breech presentation on outcomes of their subsequent pregnancy.
- To compare planned cesarean section versus planned vaginal delivery for perinatal outcomes in both the index and subsequent pregnancies.
Main Methods:
- Nationwide population-based cohort study in the Netherlands (1999-2007).
- Inclusion of women with a preterm breech delivery and a subsequent delivery.
- Comparison of planned cesarean section versus planned vaginal delivery for perinatal outcomes.
Main Results:
- 1543 women were identified; 17% had a planned cesarean section and 83% had a planned vaginal delivery in the first pregnancy.
- In the subsequent pregnancy, perinatal mortality was 1.1% for planned cesarean and 0.5% for planned vaginal delivery (aOR 1.8; 95% CI 0.31-10.1).
- Composite adverse neonatal outcome was 2.3% for planned cesarean versus 1.5% for planned vaginal delivery (aOR 1.5; 95% CI 0.55-4.2).
Conclusions:
- Planned cesarean section in women with preterm breech delivery does not reduce perinatal mortality or morbidity in the subsequent pregnancy.
- Maternal morbidity rates were also not reduced by planned cesarean section over two pregnancies.
- Findings suggest similar overall risks for planned cesarean versus planned vaginal delivery in this cohort.
Related Concept Videos
Development of the Oral Microbiota
37
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
37
Pathophysiology of Diabetes
4.4K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.4K
Mitral Valve Prolapse III: Nursing Management
532
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
532
Teratogenicity
4.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.5K

